A rating of 63 puts 22nd Century Group Inc (XXII) near the middle of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. 22nd Century Group Inc's score of 63 means it scores higher than 63% of stocks in the industry. 22nd Century Group Inc also received an overall rating of 44, putting it above 44% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 111 out of the 148 industries.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
Where Does 22nd Century Group Inc (XXII) Stock Fall in the Drug Manufacturers - Specialty & Generic Field After It Is Down -17.42% This Week?
Mentioned in this article
XXII has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on XXII!